Oracle (ORCL) PT Raised to $115 at Morgan Stanley, 'outstanding uncertainties surrounding installed base'

Morgan Stanley analyst Keith Weiss raised the price target on Oracle (NYSE: ORCL) to $115.00 (from $106.00) while maintaining a Equalweight rating.

The analyst comments " Despite potential opportunities surrounding OCI, existing database customers and cloud-based ERP applications, questions remain surrounding the path for forward EPS growth with the Cerner acquisition and slowing pace of share repurchases. While incrementally more positive on the trajectory of top-line growth at Oracle, given outstanding uncertainties surrounding installed base migration and margins, we remain Equal-weight with a price target of $115."

You May Also Be Interested In

• San Juan Regional adopts Oracle Health tools to improve bed management
• Securitize Corp (SECZ) PT Raised to $12 at StoneX on 'Innovation Exemption'
• DraftKings Inc. (DKNG) PT Lowered to $48 at UBS on Updated Estimates Post Q2